Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
about
MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine responseFrom the Outside-In: The Francisella tularensis Envelope and VirulenceSubversion of host recognition and defense systems by Francisella sppComparative review of Francisella tularensis and Francisella novicidaStructural Characterization of Closely Related O-antigen Lipopolysaccharide (LPS) Chain Length RegulatorsFine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensisNovel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainAdherence and uptake of Francisella into host cellsHost-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis.Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages.Molecular composition of the alveolar lining fluid in the aging lung.A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemiaEnhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112ΔiglB::fljB.Roles for wbtC, wbtI, and kdtA Genes in Lipopolysaccharide Biosynthesis, Protein Glycosylation, Virulence, and Immunogenicity in Francisella tularensis2 Strain SCHU S4.Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes.Genetic diversity within the genus Francisella as revealed by comparative analyses of the genomes of two North American isolates from environmental sources.A mathematical model of CR3/TLR2 crosstalk in the context of Francisella tularensis infection.IKKβ in myeloid cells controls the host response to lethal and sublethal Francisella tularensis LVS infection.Type A Francisella tularensis acid phosphatases contribute to pathogenesis.Invasion of erythrocytes by Francisella tularensisFrancisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide o-antigen, core and lipid a and affects intramacrophage survival and vaccine efficacy.Common ancestry and novel genetic traits of Francisella novicida-like isolates from North America and Australia as revealed by comparative genomic analyses.Production of anti-LPS IgM by B1a B cells depends on IL-1β and is protective against lung infection with Francisella tularensis LVSCharacterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficienciesPseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.The waaL gene mutation compromised the inhabitation of Enterobacter sp. Ag1 in the mosquito gut environment.O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages.Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan.Characterization of protein glycosylation in Francisella tularensis subsp. holarctica: identification of a novel glycosylated lipoprotein required for virulence.Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum.Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia.Metabolic labeling to characterize the overall composition of Francisella lipid A and LPS grown in broth and in human phagocytes.The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophilsComparative phosphoproteomics reveals components of host cell invasion and post-transcriptional regulation during Francisella infection.NaxD is a deacetylase required for lipid A modification and Francisella pathogenesisWorking toward the future: insights into Francisella tularensis pathogenesis and vaccine development.Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia.Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system.Immunity to Francisella.
P2860
Q21142683-2C801444-0CA9-4C24-B1AB-D4C617268469Q26771366-220DF325-933C-4380-93A0-D84F5B144148Q27025594-0E6619C5-09DE-4119-A54A-D7E9DA7AD5E5Q27027396-A25BEE25-696A-4A9A-908F-FEFD893E7EC3Q27678135-967EE797-BA67-4EF0-B9B1-7F308035DE43Q28485277-95B9E7E8-415A-4B94-B734-91AD7787A3BFQ30411506-D1B0A08B-E4D4-4EB0-BF92-98FBB3C4502FQ30414697-78745833-F8A0-4D8E-AAE1-02D8DA076E53Q31027494-AE806AF7-1657-4FA3-9FA6-B3ECD816BED9Q33401591-CA1A2664-AAE1-4D09-A196-AEB6BD317993Q33747324-77468620-673B-4C3A-B867-B1A894CFFA0EQ33848654-C1D1C3AA-8548-4F60-94A6-DA4FB8AE9865Q33983961-48A10812-1722-43E2-B052-9E35DB8C8F7FQ34074366-852976C8-FB04-4FA2-898E-EF33D18C2A23Q34077689-CB65A127-54FC-4510-AF7C-1DCD4FC43C61Q34186778-CD58D990-6CCA-4E7B-A7DA-6DFE10B740AFQ34393102-6B18BA7B-D324-45B5-B6A7-A0C253F61AB4Q34468902-E630398B-1C4C-4FBB-BB3C-E5F62C006DE9Q34562654-663786D4-7F67-43A5-99BA-EB10AD224204Q34607126-0580EF4A-C95E-4C72-A129-89ACD3EC1A97Q35016664-B95DC2BA-7889-4E38-B595-CAFAF5CE7FFEQ35029406-19A7542A-E98F-4C71-ACAD-FF5D911C5279Q35139081-7A1C05C1-8C3E-4F61-91DE-46B2FA48B779Q35175319-BCFBA222-8A84-4182-81EE-6F58016366B9Q35569969-268F2F55-CF19-4453-A135-7358FBEEB1E8Q35738790-207D0516-B92E-451E-9687-DCF5E28AE6D3Q35755260-4B40FB9B-2284-48A4-B47F-FAA674C22899Q35805342-18E76E65-32D9-4406-8EF9-CD235ABD480CQ35851086-474AA25E-E91F-4D5D-87A9-AAA9BEFC3205Q36089867-2B2A9FF1-E94A-44FA-BEE5-8EC2DAACCBC7Q36218553-5997D93B-98D2-46E0-825F-C23E58E97321Q36623123-473EB204-E2F3-4C93-A7E4-B34891751DFEQ37228144-59EDA1AB-026C-45A1-BF16-E2F2B397D9EBQ37274222-85F87B38-F401-40B1-8BC5-4F63123A56B2Q37289426-077D8DAD-C699-4B52-A11B-7D98CBA7867EQ37345795-44B44C1C-A33D-4A3A-B940-0A05ED414930Q37451520-670F1280-704F-4BE4-8903-506A895112F8Q37713242-5C819DCF-8745-434B-B0A5-3A6141150794Q37825928-F46E6B67-7C1C-41BD-B3D9-801683DB6452Q37891779-A495F2C4-E877-4AA3-976E-6B619A0D8FEF
P2860
Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evasion of complement-mediated ...... lipopolysaccharide O antigen.
@en
Evasion of complement-mediated ...... lipopolysaccharide O antigen.
@nl
type
label
Evasion of complement-mediated ...... lipopolysaccharide O antigen.
@en
Evasion of complement-mediated ...... lipopolysaccharide O antigen.
@nl
prefLabel
Evasion of complement-mediated ...... lipopolysaccharide O antigen.
@en
Evasion of complement-mediated ...... lipopolysaccharide O antigen.
@nl
P2093
P2860
P1476
Evasion of complement-mediated ...... lipopolysaccharide O antigen.
@en
P2093
Corey D Clay
John S Gunn
Larry S Schlesinger
Shilpa Soni
P2860
P304
P356
10.4049/JIMMUNOL.181.8.5568
P407
P577
2008-10-01T00:00:00Z